Literature DB >> 2088766

A re-evaluation of the HSA-piroxicam interaction.

F Brée1, S Urien, P Nguyen, P Riant, E Albengres, J P Tillement.   

Abstract

Piroxicam binding to HSA was studied using equilibrium dialysis and fluorescence methods. It was shown that this drug, like its analogs isoxicam and tenoxicam, binds to the apazone locus (site I area) and to a lesser extent to the diazepam site (site II). The piroxicam binding to HSA can be modulated by various specific ligands--apazone, warfarin, diazepam, ibuprofen--and these drug interactions have to be considered not only as potential displacement from the HSA binding sites but also in terms of induced allosteric effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2088766     DOI: 10.1007/BF03190219

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  15 in total

1.  The characterization of two specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

2.  Binding of piroxicam to human serum albumin: effect of piroxicam on warfarin and diazepam binding.

Authors:  K Matsuyama; A C Sen; J H Perrin
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

3.  A study on the allosteric interaction between the major binding sites of human serum albumin using microcalorimetry.

Authors:  J H Dröge; L H Janssen; J Wilting
Journal:  Biochim Biophys Acta       Date:  1985-03-01

4.  Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.

Authors:  K J Fehske; U Schläfer; U Wollert; W E Müller
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

5.  Quantitative assessment of the competitive binding of anionic ligands to albumin.

Authors:  H Meisner; J Stair; K Neet
Journal:  Mol Pharmacol       Date:  1980-09       Impact factor: 4.436

6.  Piroxicam, a novel anti-inflammatory agent.

Authors:  E H Wiseman; Y H Chang; J G Lombardino
Journal:  Arzneimittelforschung       Date:  1976

7.  Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.

Authors:  U Kragh-Hansen
Journal:  Mol Pharmacol       Date:  1988-08       Impact factor: 4.436

8.  Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies.

Authors:  D C Hobbs; T M Twomey
Journal:  J Clin Pharmacol       Date:  1979 May-Jun       Impact factor: 3.126

9.  Blood distribution of tenoxicam in humans: a particular HSA drug interaction.

Authors:  F Bree; P Nguyen; S Urien; P Riant; E Albengres; H Fenner; J P Tillement
Journal:  Fundam Clin Pharmacol       Date:  1989       Impact factor: 2.748

Review 10.  Piroxicam: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

View more
  6 in total

1.  A fluorescence-based high throughput assay for the determination of small molecule-human serum albumin protein binding.

Authors:  Megan M McCallum; Alan J Pawlak; William R Shadrick; Anton Simeonov; Ajit Jadhav; Adam Yasgar; David J Maloney; Leggy A Arnold
Journal:  Anal Bioanal Chem       Date:  2014-01-05       Impact factor: 4.142

2.  Blood-to-brain transfer of various oxicams: effects of plasma binding on their brain delivery.

Authors:  P Jolliet; N Simon; F Brée; S Urien; A Pagliara; P A Carrupt; B Testa; J P Tillement
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

3.  Nimesulide binding to components within blood.

Authors:  F Bree; P Nguyen; S Urien; E Albengres; A Macciocchi; J P Tillement
Journal:  Drugs       Date:  1993       Impact factor: 9.546

4.  Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin.

Authors:  Keishi Yamasaki; Saya Hyodo; Kazuaki Taguchi; Koji Nishi; Noriyuki Yamaotsu; Shuichi Hirono; Victor Tuan Giam Chuang; Hakaru Seo; Toru Maruyama; Masaki Otagiri
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

5.  Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites.

Authors:  Keishi Yamasaki; Koji Nishi; Makoto Anraku; Kazuaki Taguchi; Toru Maruyama; Masaki Otagiri
Journal:  Biochem Biophys Rep       Date:  2018-05-11

6.  Investigation of human albumin-induced circular dichroism in dansylglycine.

Authors:  Fernanda S Graciani; Valdecir F Ximenes
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.